Biotech

All Articles

Bicara, Zenas look for IPOs to push late-phase properties toward market

.Bicara Rehabs and also Zenas Biopharma have offered new incentive to the IPO market along with fili...

Genentech to finalize cancer cells immunology analysis division

.Genentech will definitely close its cancer cells immunology analysis team, as well as unit mind and...

Kezar goes down strong lump but to confirm its really worth in phase 1 test

.Kezar Life Sciences is dropping its unpromising period 1 sound cyst medication as the biotech goes ...

Acelyrin drops izokibep, lets go 3rd of personnel

.In spite of izokibep sustaining its own newfound winning streak in the clinic, Acelyrin is no longe...

Rivus' stage 2 obesity-related cardiac arrest trial hits endpoint

.Rivus Pharmaceuticals has actually plumped up the prospects of its own fat-busting, muscle-sparing ...

Ovid standstills preclinical job, IV system after soticlestat stop working

.Ovid Rehab currently disclosed last month that it was trimming its headcount as the company gets th...

Eli Lilly opens up $700M nucleic acid R&ampD facility in Boston Port

.Eli Lilly has actually opened a $700 thousand R&ampD center in the Boston Port, enhancing its own R...

Boundless Biography creates 'moderate' discharges five months after $100M IPO

.Merely 5 months after getting a $one hundred thousand IPO, Boundless Biography is already giving up...

Halda's $126M will definitely progress 'secure as well as get rid of' growth medicines

.The preliminary phases of oncology R&ampD aren't short of appealing brand-new methods, and also Hal...

Lykos 'remorses' certainly not disclosing study offenses with publisher

.Psychopharmacology has actually drawn 3 articles concerning midstage medical test information asses...